HER2ea-HER2eb-HER2ec

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameHER2ea-HER2eb-HER2ec
Drug Alias NameTBEE-3
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 antagonists
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiotecnol Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiotecnol Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A